Extended Data Table 6:
Figure panels: | Fig. 2g–h, Ext. Data Fig. 4b | Ext. Data Fig. 4d–e, Ext Data Fig. 4h–i | Fig. 2i–j, Ext. Data Fig. 4c | Ext. Data Fig. 4f–g Ext. Data Fig. 4j–k | Fig. 2L | Ext. Data Fig. 4m |
Control | 20 | 18 | 20 | 18 | 18 | 10 |
CCL2 | 9 | 8 | 8 | 8 | ||
PGE2 | 12 | 10 | 10 | |||
PGE2 + EP2 antagonist | 11 | 8 | ||||
IL-1β | 12 | 10 | 12 | 10 | 10 | |
IL-1β + PGE2 | 9 | 8 | ||||
IL-1β + COX2 inhibitor | 10 | 10 | ||||
IL-1β + COX2 inhibitor +PGE2 | 10 | 8 | ||||
IL-1β + COX2 inhibitor +PGE2 +EP2 antagonist | 10 | 7 |